Abstract
An agonist analogue of luteinising hormone releasing hormone (buserelin) was successfully used to treat women with endometriosis. A dose of 200 micrograms administered intranasally thrice daily was found to be effective in five patients, in whom the endometriotic lesions resolved after six months' treatment. Failure occurred in a sixth patient, who received only 400 micrograms once daily. Anovulation was induced in all subjects together with suppression of menstruation after the first month of treatment. Symptoms of abdominal pain, dysmenorrhoea, and dyspareunia were relieved during treatment, and one previously infertile patient conceived within two months of stopping treatment. No side effects were reported with this dosage, and the results suggest a new form of treatment for patients with endometriosis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bergquist C., Nillius S. J., Wide L. Intranasal LHRH agonist treatment for inhibition of ovulation in women: clinical aspects. Clin Endocrinol (Oxf) 1982 Jul 1;17(1):91–98. doi: 10.1111/j.1365-2265.1982.tb02638.x. [DOI] [PubMed] [Google Scholar]
- Fraser H. M. Effect of treatment for 1 year with a luteinizing hormone-releasing hormone agonist on ovarian, thyroidal, and adrenal function and menstruation in the stumptailed monkey (Macaca arctoides). Endocrinology. 1983 Jan;112(1):245–253. doi: 10.1210/endo-112-1-245. [DOI] [PubMed] [Google Scholar]
- Fraser H. M., Sandow J., Krauss B. Antibody production against an agonist analogue of luteinizing hormone-releasing hormone: evaluation of immunochemical and physiological consequences. Acta Endocrinol (Copenh) 1983 Jun;103(2):151–157. doi: 10.1530/acta.0.1030151. [DOI] [PubMed] [Google Scholar]
- Friedlander R. L. The treatment of endometriosis with Danazol. J Reprod Med. 1973 Apr;10(4):197–199. [PubMed] [Google Scholar]
- Howie P. W., McNeilly A. S., Houston M. J., Cook A., Boyle H. Fertility after childbirth: infant feeding patterns, basal PRL levels and post-partum ovulation. Clin Endocrinol (Oxf) 1982 Oct;17(4):315–322. doi: 10.1111/j.1365-2265.1982.tb01596.x. [DOI] [PubMed] [Google Scholar]
- KISTNER R. W. The use of newer progestins in the treatment of endometriosis. Am J Obstet Gynecol. 1958 Feb;75(2):264–278. doi: 10.1016/0002-9378(58)90384-3. [DOI] [PubMed] [Google Scholar]
- Kistner R. W., Siegler A. M., Behrman S. J. Suggested classification for endometriosis: relationship to infertility. Fertil Steril. 1977 Sep;28(9):1008–1010. [PubMed] [Google Scholar]
- Lauersen N. H., Wilson K. H., Birnbaum S. Danazol: an antigonadotropic agent in the treatment of pelvic endometriosis. Am J Obstet Gynecol. 1975 Dec 1;123(7):742–747. doi: 10.1016/0002-9378(75)90499-8. [DOI] [PubMed] [Google Scholar]
- Lemay A., Quesnel G. Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist. Fertil Steril. 1982 Sep;38(3):376–379. doi: 10.1016/s0015-0282(16)46522-2. [DOI] [PubMed] [Google Scholar]
- Meldrum D. R., Chang R. J., Lu J., Vale W., Rivier J., Judd H. L. "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab. 1982 May;54(5):1081–1083. doi: 10.1210/jcem-54-5-1081. [DOI] [PubMed] [Google Scholar]
- Schmidt-Gollwitzer M., Hardt W., Schmidt-Gollwitzer K., von der Ohe M., Nevinny-Stickel J. Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control? Contraception. 1981 Feb;23(2):187–195. doi: 10.1016/0010-7824(81)90104-9. [DOI] [PubMed] [Google Scholar]
- Werlin L. B., Hodgen G. D. Gonadotropin-releasing hormone agonist suppresses ovulation, menses, and endometriosis in monkeys: an individualized, intermittent regimen. J Clin Endocrinol Metab. 1983 Apr;56(4):844–848. doi: 10.1210/jcem-56-4-844. [DOI] [PubMed] [Google Scholar]